{"id":760,"date":"2015-07-21T16:49:57","date_gmt":"2015-07-21T20:49:57","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=760"},"modified":"2015-07-21T16:49:57","modified_gmt":"2015-07-21T20:49:57","slug":"secondaries-announced-7-21-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-7-21-2015\/","title":{"rendered":"Secondaries announced 7.21.2015"},"content":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n

Company: \tDynavax
\nSymbol: \tDVAX
\nPrice: \t\tLast trade $27.80
\nTrade Date: \t7\/22
\nShares: \t3.6 million
\nUnderwriter(s) \tCowen, RBC, William Blair
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tExelixis
\nSymbol: \tEXEL
\nPrice: \t\tLast trade $6.06
\nTrade Date: \t7\/22
\nShares: \t20 million
\nUnderwriter(s) \tCowen & Co., William Blair, Stifel
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tFibrocell Science
\nSymbol: \tFCSC
\nPrice: \t\tLast trade $5.87
\nTrade Date: \t7\/22
\nShares: \tTBD
\nUnderwriter(s) \tWells Fargo Securities
\nCo Manager(s)\tRoth Capital Partners, Griffin Securities
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tRadius Health, Inc.
\nSymbol: \tRDUS
\nPrice: \t\tLast trade $78.29
\nTrade Date: \t7\/23
\nShares: \t3.2 million
\nUnderwriter(s) \tJ.P. Morgan, BofA Merrill Lynch, Deutsche Bank Securities, Cowen & Co.
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tPattern Energy Group Inc.
\nSymbol: \tPEGI
\nPrice: \t\tLast trade $25.74
\nTrade Date: \t7\/23
\nShares: \t4.9 million
\nUnderwriter(s) \tBMO, BofA Merrill Lynch, Citigroup
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tSeritage Growth Properties-BLOCK
\nSymbol: \tSRG
\nPrice: \t\tLast trade $40.38
\nTrade Date: \t7\/22
\nShares: \t1.45 million
\nUnderwriter(s) \tMorgan Stanley
\nRating=Subscription Needed<\/a><\/p>\n

Company: \tRegulus Therapeutics Inc.-BLOCK
\nSymbol: \tRGLS
\nPrice: \t\tLast trade $10.21
\nTrade Date: \t7\/22
\nShares: \t2.33 million
\nUnderwriter(s) \tUBS
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Dynavax Symbol: DVAX Price: Last trade $27.80 Trade Date: 7\/22 Shares: 3.6 million Underwriter(s) Cowen, RBC, William Blair Rating=Subscription Needed Company:[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[553,554,555,91,52,557,556],"class_list":["post-760","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-dvax","tag-exel","tag-fcsc","tag-pegi","tag-rdus","tag-rgls","tag-srg"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=760"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/760\/revisions"}],"predecessor-version":[{"id":761,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/760\/revisions\/761"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}